Modulating Intensity and Dosage of Aphasia Scripts

NCT ID: NCT04138940

Last Updated: 2025-05-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

85 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-21

Study Completion Date

2024-12-04

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate how changing conditions of speech-language treatment (namely, amount of repetition and distribution of practice schedule) affects the language outcome of participants with aphasia following a stroke. Using a computer based speech and language therapy program, participants will practice conversational scripts that are either short or long. Participants will practice for either 2 weeks (5 days a week) or for 5 weeks (2 days a week).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Determining the optimal intensity of treatment is essential to the design and implementation of any treatment program for aphasia. Yet, treatment intensity is a complex construct and information on the variables modulating it remain ambiguous and limited. Studies reported in the neuroscience and clinical literature support the need for intensive treatment to induce long-term neuroplastic changes while the cognitive psychology literature suggests that learning is best maintained with distributed schedules. A few studies have looked at dose parameters for single word naming tasks, but there is limited evidence regarding dose parameters for treatments that focus on training the production of larger units, such as sentences or even connected discourse. One approach that is frequently used clinically and has evidence for its efficacy is script training. Little is currently known regarding the optimum dose of script training (i.e., the number of repetitions over time of each sentence within the script) that is required to promote the best outcomes.

This study investigates the effects of modulating stimulus variables, specifically stimulus practice distribution and stimulus repetition. We use a baseline script treatment that has experimental support regarding its efficacy, and that allows the manipulation of these variables. To ensure independence and fidelity, treatment is provided in a controlled computer environment (desktop and tablet). To avoid clinician-related variables such as expertise and personality factors that may influence treatment, sentences are modeled during treatment by an anthropomorphic agent with high visual speech intelligibility and affective expressions.

With regard to "best outcomes", generalization is the ultimate goal of any treatment approach. Therefore, the primary outcome is a generalization measure of conversation. Secondary measures address short-term acquisition, longer-term maintenance, and stimulus and response generalization for assessing gain over baseline, differential effects, and interactions. A mobile-connected wireless wearable laryngeal sensor allows tracking of talk time at home and in the community as a measure of treatment effectiveness and transfer. For privacy, it does not record audio.

Results and computational models of learning (generalization, short-term acquisition, and longer-term maintenance) will contribute new evidence to fill critical gaps in current scientific understanding regarding the effectiveness and clinical application of aphasia treatment approaches. More generally, findings will help to inform clinical practice and treatment of neurologic communication disorders; the virtual clinician guided intervention that the proposal develops has the potential to reduce costly clinician-client time otherwise required for long-term rehabilitation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aphasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators
Single (Outcomes Assessor)

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Distributed, Short Script

Participant practices for 1 hour, 2 days a week for 5 weeks using a 5 sentence-long script.

Group Type EXPERIMENTAL

Script Training

Intervention Type BEHAVIORAL

Participant uses a computer program to practice scripts with a virtual therapist.

Distributed, Long Script

Participant practices for 1 hour, 2 days a week for 5 weeks using a 10 sentence-long script.

Group Type EXPERIMENTAL

Script Training

Intervention Type BEHAVIORAL

Participant uses a computer program to practice scripts with a virtual therapist.

Massed, Short Script

Participant practices for 1 hour, 5 days a week for 2 weeks using a 5 sentence-long script.

Group Type EXPERIMENTAL

Script Training

Intervention Type BEHAVIORAL

Participant uses a computer program to practice scripts with a virtual therapist.

Massed, Long Script

Participant practices for 1 hour, 5 days a week for 2 weeks using a 10 sentence-long script.

Group Type EXPERIMENTAL

Script Training

Intervention Type BEHAVIORAL

Participant uses a computer program to practice scripts with a virtual therapist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Script Training

Participant uses a computer program to practice scripts with a virtual therapist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men or women with diagnosis of aphasia
* Left-hemisphere stroke
* Aphasia Quotient score between 40-80 on the Western Aphasia Battery-Revised
* At least 6 months post stroke
* Completed at least eighth grade education
* Premorbidly literate in English
* Visual acuity no worse than 20/100 corrected in the better eye
* Auditory acuity no worse than 30 dB HL on pure tone testing, aided in better ear
* Not receiving speech-language therapy at the time of study

Exclusion Criteria

* Any other neurological condition (other than cerebral vascular disease) that could potentially affect cognition or speech, such as Parkinson's Disease, Alzheimer's Dementia, traumatic brain injury
* Any significant psychiatric history prior to the stroke, such as severe major depression or psychotic disorder requiring hospitalization; subjects with mood disorders who are currently stable on treatment will be considered
* Active substance abuse
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

Sponsor Role collaborator

Northwestern University

OTHER

Sponsor Role collaborator

University of Colorado, Boulder

OTHER

Sponsor Role collaborator

Shirley Ryan AbilityLab

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Leora Cherney

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leora Cherney, PhD, CCC-SLP

Role: PRINCIPAL_INVESTIGATOR

Shirley Ryan Abilitylab, Northwestern University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shirley Ryan Abilitylab

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1R01DC016979-01A1

Identifier Type: NIH

Identifier Source: secondary_id

View Link

STU00209618

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rhythm-based Intervention in Aphasia
NCT04581564 TERMINATED NA
Impact of Group Participation on Adults With Aphasia
NCT05520528 ACTIVE_NOT_RECRUITING NA